Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameCarsgen-B
Stock Code02171
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities我們是一家在中國及美國擁有業務的生物製藥公司,專注於治療血液惡性腫瘤和實體瘤的創新CAR-T細胞療法。
Listing Date2021-06-18
Listing Rules EraOld Rules
Listing Rules Chapter18A生物科技
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)上海市徐匯區銀都路388號12幢
Business Address (Hong Kong)香港 皇后大道東183號 合和中心54樓
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitecarsgen.com
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 32.80 / shares
Offer Price RangeFinal offer price only, no range
Lot Size500 shares
Entry ThresholdHK$ 16,400
Par ValueTo be extracted
Offer Period2021-06-07 to 2021-06-10
Global Offering Shares94,747,000 shares
HK Public Offer Shares (Initial)9,475,000 shares (10.0%)
Public Offer Lots (Initial)18,950lots (Pool A9,475lots,Pool B9,475lots)
International Placing Shares (Initial)85,272,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO567,346,696 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone Share49.9%
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 3,107,701,600

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 500 HK$ 16,400
2 lots 1,000 HK$ 32,800
3 lots 1,500 HK$ 49,200
4 lots 2,000 HK$ 65,600
5 lots 2,500 HK$ 82,000
6 lots 3,000 HK$ 98,400
7 lots 3,500 HK$ 114,800
8 lots 4,000 HK$ 131,200
9 lots 4,500 HK$ 147,600
10 lots 5,000 HK$ 164,000
12 lots 6,000 HK$ 196,800
14 lots 7,000 HK$ 229,600
16 lots 8,000 HK$ 262,400
18 lots 9,000 HK$ 295,200
20 lots 10,000 HK$ 328,000
30 lots 15,000 HK$ 492,000
40 lots 20,000 HK$ 656,000
50 lots 25,000 HK$ 820,000
60 lots 30,000 HK$ 984,000
70 lots 35,000 HK$ 1,148,000
80 lots 40,000 HK$ 1,312,000
90 lots 45,000 HK$ 1,476,000
100 lots 50,000 HK$ 1,640,000
120 lots 60,000 HK$ 1,968,000
140 lots 70,000 HK$ 2,296,000
160 lots 80,000 HK$ 2,624,000
180 lots 90,000 HK$ 2,952,000
200 lots 100,000 HK$ 3,280,000
300 lots 150,000 HK$ 4,920,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
400 lots 200,000 HK$ 6,560,000
500 lots 250,000 HK$ 8,200,000
600 lots 300,000 HK$ 9,840,000
700 lots 350,000 HK$ 11,480,000
800 lots 400,000 HK$ 13,120,000
900 lots 450,000 HK$ 14,760,000
1,000 lots 500,000 HK$ 16,400,000
1,200 lots 600,000 HK$ 19,680,000
1,400 lots 700,000 HK$ 22,960,000
1,600 lots 800,000 HK$ 26,240,000
1,800 lots 900,000 HK$ 29,520,000
2,000 lots 1,000,000 HK$ 32,800,000
3,000 lots 1,500,000 HK$ 49,200,000
4,000 lots 2,000,000 HK$ 65,600,000
5,000 lots 2,500,000 HK$ 82,000,000
6,000 lots 3,000,000 HK$ 98,400,000
7,000 lots 3,500,000 HK$ 114,800,000
8,000 lots 4,000,000 HK$ 131,200,000
9,475 lots 4,737,500 HK$ 155,390,000

Stock Connect Inclusion Analysis

Avg Daily HK Mkt Cap HK$ 8.69B
Analysis Result Already included in Stock Connect (both)

Valuation & Financials

Market Cap (at Offer Price)HK$ 18,608,971,628
Pre-IPO Valuation (Last Round)Not disclosed
P/E Ratio不適用(公司處於虧損狀態)
Profit/Loss Status虧損人民幣1,064.0百萬元
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 RMB
Balance Sheet
Item 20192020
Cash and cash equivalents 568,672667,789
Total current assets 662,717761,760
Total assets 772,856877,710
Total current liabilities 781,649887,699
Total liabilities 820,756927,788
Total equity -470,768-550,078
Equity attributable to owners -570,659-549,087
Cash Flow Statement
Item 20192020
Net cash from operating activities -560,762-665,083
Net cash from investing activities 552,661-677,082
Net cash from financing activities 670,771765,081
Net increase in cash 559,680566,074
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 30.0
First Day OpenHK$ 27.05
First Day Change-8.54%
First Day Volume54398500.0
First Day Turnover1608210000.0
Use of Proceeds
1、約882.1百萬港元(113.7百萬美元)(或約30%的所得款項凈額)將用于為進一步開發我們的核心候選產品BCMA CAR-T (CT053)提供資金; 2、約911.6百萬港元(117.5百萬美元)(或約31%的所得款項凈額)將用于為我們正在進行及已籌劃的其他管線候選產品的研發活動提供資金; 3、約588.2百萬港元(75.8百萬美元)(或約20%的所得款項凈額)用于培養全面的制造及商業化能力; 4、約147.0百萬港元(37.9百萬美元)(或約10%的所得款項凈額)用于繼續升級CAR-T技術及為早期研發活動提供資金; 5、約264.7百萬港元(34.1百萬美元)(或約9%的所得款項凈額)將用于營運資金及其他一般公司用途。

Underwriting Syndicate

Joint Sponsors (2)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 UBS Securities Hong Kong Limited CE BIN466
Overall Coordinators (4)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 UBS Securities Hong Kong Limited CE BIN466 CLSA LIMITED CE AAB893 Credit Suisse (Hong Kong) Limited CE AAO017
Joint Bookrunners (4)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 UBS Securities Hong Kong Limited CE BIN466 CLSA LIMITED CE AAB893 Credit Suisse (Hong Kong) Limited CE AAO017
Joint Lead Managers (4)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 UBS Securities Hong Kong Limited CE BIN466 CLSA LIMITED CE AAB893 Credit Suisse (Hong Kong) Limited CE AAO017

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 CloudAlpha Master Fund 235,930,400 HKD — 7.59% — 6 months 2021-12-18
2 Dymon Asia Capital (Singapore) Pte. Ltd. 67,518,800 HKD — 2.17% — 6 months 2021-12-18
3 Foresight Orient Global Superior Choice SPC 202,556,400 HKD — 6.52% — 6 months 2021-12-18
4 LAV Amber Limited 337,594,000 HKD — 10.86% — 6 months 2021-12-18
5 WT Asset Management Limited 135,037,600 HKD — 4.35% — 6 months 2021-12-18
6 常春藤资产管理(香港)有限公司 67,518,800 HKD — 2.17% — 6 months 2021-12-18
7 广发基金管理有限公司 135,037,600 HKD — 4.35% — 6 months 2021-12-18
8 南方基金管理股份有限公司 67,518,800 HKD — 2.17% — 6 months 2021-12-18
9 新华资本管理有限公司 303,449,200 HKD — 9.76% — 6 months 2021-12-18

Directors & Management

PositionChinese nameEnglish Name
Chairman李宗海—
Company Secretary呂穎一—
No director data available.

Major Shareholders

Major Shareholders & Holdings李博士、郭炳森先生、王博士、郭華清先生等一致行動方,緊隨全球發售完成後合共持有約37.92%股權。
About this page

This page shows Carsgen-B (02171) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect